Hugh O'Dowd, TherapeuticsMD CEO
TherapeuticsMD shares crater as anticipated M&A deal falls through
Six weeks after announcing an offer to be acquired for nearly $177 million, TherapeuticsMD is now saying the deal is off.
Execs kept it short …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
